Eisai Transfers Rights to Receive Royalties Outside of Japan for EZH2 Inhibitor Tazemetostat to Royalty Pharma
- Written by ACN Newswire - Press Releases
Tazemetostat is a first-in-class, oral EZH2 inhibitor discovered by Epizyme,...
.
Work-life Balance Key to Solving Construction Talent Shortage
New data from leading talent company Randstad Australia shows flexible working and work-life balance could be critical to addressing ongoing talen...
How to Apply for More Jobs in Less Time Using AI Automation
Most job seekers spend 11 to 14 hours per week on applications and still hear nothing back. That's not a motivation problem. That's a process proble...
Why Middle Australia Is Quietly Driving the Shift Away From Car Ownership
The narrative around changing attitudes to car ownership has long focused on Gen Z. Younger Australians are often portrayed as the generation movi...
Launchd Acquires WeAreTENZING as ANZ Creator Economy Spend Nears $1 Billion
Launchd, Australia's leading talent-first creator economy group, has acquired WeAreTENZING, one of New Zealand's most respected talent agencies, b...
Time to punch above our weight and stop shadowboxing on AI
Australia prides itself on being an innovation economy. We celebrate startups, talk about productivity, and lean into our reputation for punching ...
Colter Bay Capital Launches as Australia’s Newest Institutional Private Credit Fund
Led by seasoned capital markets veteran Mark Wang, the fund is purpose-built to serve Australia’s most productive yet chronically underserved busi...